Global Sarcopenia Treatments Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 151858
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 108
  • list Pharmaceuticals and Healthcare

Sarcopenia is the degenerative loss of skeletal muscle mass (0.5-1% loss per year after the age of 50), quality and strength associated with aging.

Scope of the Report:

Sarcopenia is characterized first by a muscle atrophy, along with a reduction in muscle tissue quality, characterized by such factors as replacement of muscle fibres with fat, an increase in fibrosis, changes in muscle metabolism, oxidative stress, and degeneration of the neuromuscular junction and leading to progressive loss of muscle function and frailty.

The global Sarcopenia Treatments market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sarcopenia Treatments.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Sarcopenia Treatments market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sarcopenia Treatments market by product type and applications/end industries.

Market Segment by Companies, this report covers

GlaxoSmithKline

GTX

Five Prime Therapeutics

Radius Health

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Presarcopenia

Sarcopenia

Severe Sarcopenia

Market Segment by Applications, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Sarcopenia Treatments Market Overview

1.1 Product Overview and Scope of Sarcopenia Treatments

1.2 Classification of Sarcopenia Treatments by Types

1.2.1 Global Sarcopenia Treatments Revenue Comparison by Types (2017-2023)

1.2.2 Global Sarcopenia Treatments Revenue Market Share by Types in 2017

1.2.3 Presarcopenia

1.2.4 Sarcopenia

1.2.5 Severe Sarcopenia

1.3 Global Sarcopenia Treatments Market by Application

1.3.1 Global Sarcopenia Treatments Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Sarcopenia Treatments Market by Regions

1.4.1 Global Sarcopenia Treatments Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Sarcopenia Treatments Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Sarcopenia Treatments Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sarcopenia Treatments Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Sarcopenia Treatments Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sarcopenia Treatments Status and Prospect (2013-2023)

1.5 Global Market Size of Sarcopenia Treatments (2013-2023)

2 Manufacturers Profiles

2.1 GlaxoSmithKline

2.1.1 Business Overview

2.1.2 Sarcopenia Treatments Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GlaxoSmithKline Sarcopenia Treatments Revenue, Gross Margin and Market Share (2016-2017)

2.2 GTX

2.2.1 Business Overview

2.2.2 Sarcopenia Treatments Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GTX Sarcopenia Treatments Revenue, Gross Margin and Market Share (2016-2017)

2.3 Five Prime Therapeutics

2.3.1 Business Overview

2.3.2 Sarcopenia Treatments Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Five Prime Therapeutics Sarcopenia Treatments Revenue, Gross Margin and Market Share (2016-2017)

2.4 Radius Health

2.4.1 Business Overview

2.4.2 Sarcopenia Treatments Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Radius Health Sarcopenia Treatments Revenue, Gross Margin and Market Share (2016-2017)

3 Global Sarcopenia Treatments Market Competition, by Players

3.1 Global Sarcopenia Treatments Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Sarcopenia Treatments Players Market Share

3.2.2 Top 10 Sarcopenia Treatments Players Market Share

3.3 Market Competition Trend

4 Global Sarcopenia Treatments Market Size by Regions

4.1 Global Sarcopenia Treatments Revenue and Market Share by Regions

4.2 North America Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

4.3 Europe Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

4.5 South America Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

5 North America Sarcopenia Treatments Revenue by Countries

5.1 North America Sarcopenia Treatments Revenue by Countries (2013-2018)

5.2 USA Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

5.3 Canada Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

5.4 Mexico Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

6 Europe Sarcopenia Treatments Revenue by Countries

6.1 Europe Sarcopenia Treatments Revenue by Countries (2013-2018)

6.2 Germany Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

6.3 UK Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

6.4 France Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

6.5 Russia Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

6.6 Italy Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Sarcopenia Treatments Revenue by Countries

7.1 Asia-Pacific Sarcopenia Treatments Revenue by Countries (2013-2018)

7.2 China Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

7.3 Japan Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

7.4 Korea Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

7.5 India Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

8 South America Sarcopenia Treatments Revenue by Countries

8.1 South America Sarcopenia Treatments Revenue by Countries (2013-2018)

8.2 Brazil Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

8.3 Argentina Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

8.4 Colombia Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Sarcopenia Treatments by Countries

9.1 Middle East and Africa Sarcopenia Treatments Revenue by Countries (2013-2018)

9.2 Saudi Arabia Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

9.3 UAE Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

9.4 Egypt Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

9.5 Nigeria Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

9.6 South Africa Sarcopenia Treatments Revenue and Growth Rate (2013-2018)

10 Global Sarcopenia Treatments Market Segment by Type

10.1 Global Sarcopenia Treatments Revenue and Market Share by Type (2013-2018)

10.2 Global Sarcopenia Treatments Market Forecast by Type (2018-2023)

10.3 Presarcopenia Revenue Growth Rate (2013-2023)

10.4 Sarcopenia Revenue Growth Rate (2013-2023)

10.5 Severe Sarcopenia Revenue Growth Rate (2013-2023)

11 Global Sarcopenia Treatments Market Segment by Application

11.1 Global Sarcopenia Treatments Revenue Market Share by Application (2013-2018)

11.2 Sarcopenia Treatments Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)

12 Global Sarcopenia Treatments Market Size Forecast (2018-2023)

12.1 Global Sarcopenia Treatments Market Size Forecast (2018-2023)

12.2 Global Sarcopenia Treatments Market Forecast by Regions (2018-2023)

12.3 North America Sarcopenia Treatments Revenue Market Forecast (2018-2023)

12.4 Europe Sarcopenia Treatments Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Sarcopenia Treatments Revenue Market Forecast (2018-2023)

12.6 South America Sarcopenia Treatments Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Sarcopenia Treatments Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Sarcopenia Treatments Picture

Table Product Specifications of Sarcopenia Treatments

Table Global Sarcopenia Treatments and Revenue (Million USD) Market Split by Prod

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery